Initiator Pharma A/S Financial Overview
Initiator Pharma A/S's market cap is currently kr208.78M. The company's EPS TTM is kr-0.093; its P/E ratio is -10.80; Initiator Pharma A/S is scheduled to report earnings on November 21, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
